Committee for Advanced Therapies (CAT) and the International Society for Cellular Therapy (ISCT) workshop: challenges and opportunities for a successful development and approval of advanced therapy medicinal products

EventHumanAdvanced therapiesInnovation

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date

Piektdiena, 25 Septembris 2015, Visu dienu

Vieta

European Medicines Agency, Amsterdam, the Netherlands

The workshop is co-organised by the European Medicines Agency's (EMA's) Commitee for Advanced Therapies (CAT) and the International Society for Cellular Therapy (ISCT) and will take place during the ISCT Europe 2015 regional meeting. During this workshop, CAT wants to reach out to advanced therapy medicinal products (ATMP) developers from academia, hospitals and industry with a programme aiming to provide insight of CAT's considerations and expectations on quality development and manufacturing issues, non-clinical testing and clinical development of ATMPs. The programme includes also a talk on the EMA/CAT support available to ATMP developers and will allow interacting directly with the regulators in an open forum discussion.

Documents

Share this page